Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Nieuwe methode schat ernst en prognose hersentumor beter in
sep 2025 | Neuro-oncologie